APrf Kirsten Gormly
School of Medicine
College of Health
Clinical radiologist with subspecilaty expertise in oncology and pelvic imaging. Clinical Senior Lecturer - The University of Adelaide, Past chair & current executive member - Abdominal Radiology Group of Australia & New Zealand, Corresponding Fellow - European Society of Gastrointestinal and Abdominal Radiology, Fellow - International Cancer Imaging Society, Member - Society of Abdomial Radiology (USA) Anorectal Disease Focused Panel. Research interests include rectal MRI, prostate cancer, Dual energy CT, improvements in radiology education and reporting, with national and international colaborations.Educational contributions predominantly involve national and international radiologist and non radiology meetings and workshops. Contributions to face to face teaching at The University of Adelaide in MS1 & MS4 and virtual lectures for MS3.
My primary research is focused on gastrointestinal and urological conditions, in particular rectal and prostate cancer. I am involved in imaging based research as well as collaborations which assess imaging as part of disease assessment and management.
I also focus on assessing the uptake and use of guidelines for technical quality and reporting in oncological imaging. Poor image quality reduces the ability to report accurately and failure to use standardised guidelines impedes the ability to compare international research findings accurately.
Assessing new imaging technologies in oncological and abdominal imaging, such as Dual energy CT, Photon counting CT, high gradient MRI systems and AI assisted MRI sequences is an additional area of research activity.
| Date | Position | Institution name |
|---|---|---|
| 2020 - ongoing | Clinical Senior Lecturer | The University of Adelaide |
| 2009 - ongoing | Radiologist | Jones Radiology |
| Date | Institution name | Country | Title |
|---|---|---|---|
| University of Adelaide | Australia | MBBS |
| Date | Title | Institution | Country |
|---|---|---|---|
| FRANZCR | Royal Australian and New Zealand College of Radiologists | Australia |
| Year | Citation |
|---|---|
| 2025 | Brown, K. J., Agarwal, A., & Gormly, K. L. (2025). Use and Perceptions of Oncology CT Structured Reports in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 69(5), 554-560. Scopus1 WoS1 |
| 2025 | Gormly, K. L. (2025). Improving radiology reporting locally and globally: who, how and why?. British Journal of Radiology, 98(1167), 330-335. |
| 2025 | Nougaret, S., Gormly, K., Lambregts, D. M. J., Reinhold, C., Goh, V., Korngold, E., . . . Brown, G. (2025). MRI of the Rectum: A Decade into DISTANCE, Moving to DISTANCED.. Radiology, 314(1), e232838-1-e232838-19. Scopus10 WoS12 Europe PMC6 |
| 2024 | Jain, A., Gormly, K. L., Glyn, T., Sammour, T., Koay, E. J., Oar, A., . . . Vatandoust, S. (2024). Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022. Asia-Pacific Journal of Clinical Oncology, 20(1), 71-80. Scopus2 WoS1 |
| 2024 | O'Callaghan, M., Bulamu, N., Gormly, K., & Jay, A. (2024). Re: Prevalence of MRI Lesions in Men Responding to a GP-led Invitation for a Prostate Health Check: A Prospective Cohort Study. European Urology, 85(4), 392-397. Europe PMC4 |
| 2023 | Nougaret, S., Rousset, P., Lambregts, D. M. J., Maas, M., Gormly, K., Lucidarme, O., . . . Hoeffel, C. (2023). MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups. Diagnostic and Interventional Imaging, 104(7-8), 311-322. Scopus9 WoS8 Europe PMC8 |
| 2023 | Gormly, K. L. (2023). Anal cancer MRI: DWI assists response assessment for squamous cell carcinoma, but achieving widespread high-quality scans remains challenging. European Radiology, 33(11), 7573-7574. Scopus1 WoS1 |
| 2023 | Seah, H. M., Choi, H. C., Bajic, N., Oakden-Rayner, L., & Gormly, K. L. (2023). Assessment of a single-pass venous phase CT chest, abdomen and pelvis and dual-energy CT in general oncology outpatients. Journal of Medical Imaging and Radiation Oncology, 67(4), 349-356. Scopus3 WoS3 Europe PMC2 |
| 2023 | Roy, A., Shepherdson, M., Gormly, K., Byrne, S., Pedersen, S., Price, T., . . . Symonds, E. L. (2023). Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancer. ESMO Gastrointestinal Oncology, 2, 100013-1-100013-7. |
| 2022 | Vatandoust, S., Wattchow, D., Sposato, L., Michael, M. Z., Leung, J., Gormly, K., . . . Karapetis, C. S. (2022). A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol. BMC Cancer, 22(1), 13 pages. Scopus8 WoS7 Europe PMC7 |
| 2022 | Nougaret, S., Rousset, P., Gormly, K., Lucidarme, O., Brunelle, S., Milot, L., . . . Hoeffel, C. (2022). Structured and shared MRI staging lexicon and report of rectal cancer: A consensus proposal by the French Radiology Group (GRERCAR) and Surgical Group (GRECCAR) for rectal cancer. Diagnostic and Interventional Imaging, 103(3), 127-141. |
| 2022 | Croft, M., Lim, W., Lavender, N., & Gormly, K. (2022). Optimising CT‐chest protocols and the added value of venous‐phase contrast timing; Observational case‐control. Journal of Medical Imaging and Radiation Oncology, 66(6), 768-775. Scopus5 WoS6 Europe PMC5 |
| 2021 | Gormly, K. (2021). Rectal MRI: the importance of high resolution T2 technique. Abdominal Radiology, 46(9), 4090-4095. Scopus11 WoS10 Europe PMC7 |
| 2021 | Gormly, K. L. (2021). High-resolution t2-weighted mri to evaluate rectal cancer: Why variations matter. Korean Journal of Radiology, 22(9), 1475-1480. Scopus12 WoS12 Europe PMC10 |
| 2019 | Raeside, M., Low, A., Cohen, P., Sutherland, P., & Gormly, K. (2019). Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting. Journal of Medical Imaging and Radiation Oncology, 63(4), 487-494. Scopus5 WoS5 Europe PMC3 |
| 2019 | Jameson, M. B., Gormly, K., Espinoza, D., Hague, W., Asghari, G., Jeffery, G. M., . . . Ackland, S. P. (2019). SPAR - A randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial. BMC Cancer, 19(1), 12 pages. Scopus15 WoS15 Europe PMC13 |
| 2018 | Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19. Scopus12 WoS9 Europe PMC9 |
| 2017 | Roy, A. C., Wattchow, D., Astill, D., Singh, S., Pendlebury, S., Gormly, K., & Segelov, E. (2017). Uncommon Anal Neoplasms. Surgical Oncology Clinics of North America, 26(1), 143-161. |
| 2016 | Gormly, K. L., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2016). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Journal of Medical Imaging and Radiation Oncology, 60(5), 607-615. Scopus7 WoS7 Europe PMC6 |
| 2016 | Raeside, M. C., Gormly, K., Neuhaus, S. J., Kotasek, D., & James, C. (2016). Primary pericardial mesothelioma presenting as multiple pericardial masses on CT. BJR CASE REPORTS, 2(1), 4 pages. WoS4 Europe PMC2 |
| 2016 | Siddiqui, M. R. S., Gormly, K. L., Bhoday, J., Balyansikova, S., Battersby, N. J., Chand, M., . . . Brown, G. (2016). Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clinical Radiology, 71(9), 854-862. Scopus69 WoS62 Europe PMC54 |
| 2015 | Gormly, K. L. M., Coscia, C., Wells, T., Tebbutt, N., Harvey, J. A., Wilson, K., . . . Price, T. (2015). MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial. Cancer Imaging, 15(S1). |
| 2009 | Gormly, K. L. M. (2009). Standardised tumour, node and metastasis reporting of oncology CT scans. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 53(4), 345-352. WoS5 Europe PMC4 |
| 2008 | Smith, G. E. C., & Gormly, K. L. M. (2008). Magnetic Resonance Imaging in the staging of cervical carcinoma: A pictorial review. Journal of Medical Imaging and Radiation Oncology, 52(5), 427-433. Scopus3 WoS3 Europe PMC3 |
| 2004 | Gormly, K., & Glastonbury, C. M. (2004). Calcified nodal metastasis from squamous cell carcinoma of the head and neck. Australasian Radiology, 48(2), 240-242. |
| 1996 | Gormly, K. L., & Langlois, S. L. P. (1996). Assessment of an online radiology reporting system. Australasian Radiology, 40(4), 408-411. |
| Year | Citation |
|---|---|
| 2007 | Hricak, H., Husband, J., Panicek, D. M., Akin, O., Gormly, K. L., Grewal, R. K., . . . Daniel, E. (2007). Contributors. In Oncologic Imaging (pp. v-viii). Elsevier. DOI |
| Year | Citation |
|---|---|
| 2024 | Brown, K., Agarwal, A., & Gormly, K. (2024). Errors in oncology CT : Analysis of a discrepancy database over 8 years. In Abstracts of the ICIS SGCR-WIRES 2024, held jointly with the 23rd International Cancer Imaging Society Annual Conference as published in Cancer Imaging Vol. 24 (pp. P22-14). Singapore: BMC. DOI |
| 2024 | Chai, N., Malalagama, G., Jameson, M., Ackland, S., & Gormly, K. (2024). SPAR Rectal MRI Technique Sub-study, with Technique and Reporting Survey in Australia and New Zealand. In ESGAR 2024 Book of Abstracts as published in Insights into Imaging Vol. 15 (pp. 30). Gothenberg, Sweden: SpringerOpen. DOI |
| 2022 | Jameson, M. B., Gormly, K., Espinoza, D., Hague, W., Jeffery, G. M., Price, T. J., . . . Ackland, S. P. (2022). SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial. In JOURNAL OF CLINICAL ONCOLOGY Vol. 40 (pp. 1 page). ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS. |
| 2021 | Gormly, K., Espinoza, D., Hague, W., Jeffrey, M., Price, T., Karapetis, C., . . . Ackland, S. (2021). SPAR: Randomised phase II study of chemoradiation with or without simvastatin as preoperative treatment for rectal cancer (an AGITG trial). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 36). WILEY. |
| 2016 | Siddiqui, M. R. S., Bhoday, J., Balyansikova, S., Battersby, N. J., Gormly, K. L., Rao, S., . . . Brown, G. (2016). Inter-observer agreement of radiologists assessing the response of rectal cancers after chemoradiation therapy according to MRI tumour regression grading (mrTRG). In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 17). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL. |
| - | Dwyer, A., Walls, A., Gormly, K., Raeside, M., & Withey, S. (2024, May 4). Optimisation and implementation of high b-value DWI using 200mT/m gradient system for clinical prostate MRI.. In ISMRM Annual Meeting. ISMRM. DOI |
SPAR: A randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer’. M Jameson, S Ackland, M Pearse , S Ngan, F Frizelle, A Stevenson, K Gormly. M Arendse. 2018
- Health Research Council on NZ (HRC) $NZ 1,399,053
- Cancer Society New Zealand $NZ 149,290,
RENO: Prospective Study of ‘Watch and Wait’ Strategy in patients with Rectal Cancer who have developed a Clinical Complete Response with concurrent Chemo-radiotherapy. C Karapetis, D Wattchow, S Vatandoust, L Sposato. CI. 2018
- AGITG innovation grant $200,000
Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests. E Symonds, GP Young, M Michael, ..... A Roy, C Karapetis, K Gormly. 2020
- AGITG innovation grant $200,000
PETACC 6 Trial: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. TJ Price, J Harvey, N Tebbutt, J Zalcberg, J Simes, G Hruby
- 2013. Cancer Australia + Cancer Council NSW 123,331 + 19,624.
- 2009-11. Cancer Australia 477,800
Contributions to the new BMS / MD Medical Course include;
MS1 & 2 imaging content
MS3 lectures:
- Imaging in Prostate cancer
- Imaging in Testicular cancer
- Imaging in Ovarian Cancer
- Imaging in Uterine cancer
- Imaging in Cervix cancer
Planned 4th year MD - face to face session; General Surgical Imaging
Extensive vocational lecturing to radiologists and other medical and allied health groups in national and international forums, including conferences and workshops.
Connect With Me
External Profiles
